Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

9823	Companies
197229	Keywords
128349	Articles
104920	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 11/17/2025 at 06:30, 2 months 22 days ago

Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio

Growth Biosimilar Formycon Dupixent FYB208
BRIEF

published on 11/13/2025 at 06:35, 2 months 26 days ago

Formycon AG confirme ses prévisions pour 2025 malgré les progrès réalisés dans ses projets et partenariats.

Résultats Financiers Partenariats Stratégiques Formycon AG Biosimilaires Expansion Du Marché
BRIEF

published on 11/13/2025 at 06:35, 2 months 26 days ago

Formycon AG Confirms 2025 Guidance Amid Pipeline and Partnership Progress

Financial Results Strategic Partnerships Formycon AG Biosimilars Market Expansion
PRESS RELEASE

published on 11/13/2025 at 06:30, 2 months 26 days ago

Formycon publishes nine-month results and confirms guidance – Pipeline progress and strong partnerships drive fiscal year 2025
Formycon AG publishes nine-month results, reaffirms 2025 guidance with strong pipeline progress and partnerships. Read about fiscal performance and strategic advancements

Formycon AG Partnerships Pipeline Progress Nine-month Results 2025 Guidance
BRIEF

published on 10/30/2025 at 06:35, 3 months 10 days ago

Formycon AG programme une conférence téléphonique sur ses résultats 2025 et les relations avec les investisseurs.

Résultats Financiers Formycon AG Conférence Téléphonique Conférences D'investisseurs Biosimilaires
BRIEF

published on 10/30/2025 at 06:35, 3 months 10 days ago

Formycon AG Schedules Conference Call for 2025 Results and Investor Engagement

Financial Results Conference Call Investor Conferences Formycon AG Biosimilars
PRESS RELEASE

published on 10/30/2025 at 06:30, 3 months 10 days ago

Formycon invites to Conference Call on 2025 Nine-Month Results and announces Participation in Investor Conferences in the 4th Quarter of 2025
Formycon AG to discuss 2025 Nine-Month Results in Conference Call and participate in Investor Conferences. Company specializes in biosimilars for various disease areas

Financial Results Conference Call Investor Conferences Formycon AG Biosimilars
BRIEF

published on 10/21/2025 at 06:35, 3 months 19 days ago

Formycon Launches Europe’s First Ranibizumab Biosimilar in Pre-filled Syringe

Teva Pharmaceuticals Ranibizumab Biosimilar Pre-filled Syringe FYB201/Ranivisio® Formycon Launch
BRIEF

published on 10/21/2025 at 06:35, 3 months 19 days ago

Formycon lance le premier biosimilaire du ranibizumab en seringue préremplie en Europe

Teva Pharmaceuticals FYB201/Ranivisio® Biosimilaire Du Ranibizumab Seringue Préremplie Lancement De Formycon
PRESS RELEASE

published on 10/21/2025 at 06:30, 3 months 19 days ago

Formycon’s FYB201/Ranivisio® sets innovative standard as Europe’s First Ranibizumab Biosimilar available in Pre-filled Syringe
Formycon's FYB201/Ranivisio® is Europe's First Ranibizumab Biosimilar available in Pre-filled Syringe, offering improved handling, accuracy, and convenience for applicants. Teva to commercialize across Europe

Europe Biosimilar Formycon Teva Ranivisio

Accesswire

Published on 02/09/2026 at 15:00, 3 hours 38 minutes ago

Gungnir Resources Inc. Announces Management And Board Changes
Published on 02/09/2026 at 14:15, 4 hours 23 minutes ago

White Gold Corp. Appoints Seasoned Mining Executive Donovan Pollitt as Strategic Advisor
Published on 02/09/2026 at 14:00, 4 hours 38 minutes ago

Paymetrex Secures First U.S. License Payment
Published on 02/09/2026 at 14:00, 4 hours 38 minutes ago

Geophysics Converge Ahead of Colosseum Deeper Drill Program
Published on 02/09/2026 at 13:00, 5 hours 38 minutes ago

Eagle Plains' Partner Refined Energy Corp. Mobilizes Geophysical Team to the Dufferin West Project, Saskatchewan

View all ACCESSWIRE

EQS Group

Published on 02/09/2026 at 17:52, 46 minutes ago

EQS-Adhoc: GESCO SE: Burden from the insolvency of a contractual partner
Published on 02/09/2026 at 17:28, 1 hour 10 minutes ago

XTPL intends to raise capital through a share offering; the goal for 2026 is next industrial implementation and launch of ODRA sales
Published on 02/09/2026 at 17:24, 1 hour 14 minutes ago

EQS-Adhoc: net digital AG Likely Exceeds 2025 Annual Forecast for Revenue and Earnings
Published on 02/09/2026 at 16:49, 1 hour 49 minutes ago

RM plc: Holding(s) in Company
Published on 02/09/2026 at 15:58, 2 hours 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Just Group plc

Les Echos

Published on 02/09/2026 at 18:00, 38 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 53 minutes ago

Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 53 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 53 minutes ago

Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 53 minutes ago

Déclaration des droits de vote à fin janvier 2026

View all LES ECHOS COMFI WIRE